All Industries

Top Therapeutics Companies

66 Therapeutics companies, sorted by total funding raised.

AN
Aspen Neuroscience

Biotech company developing the first autologous iPSC-derived neuron replacement cell therapy for ...

San Diego, United StatesBiotech, Healthcare
Funding undisclosed
BT
Beam Therapeutics
IPO

Biotechnology company developing precision genetic medicines through proprietary base editing tec...

Cambridge, United StatesBiotech, Gene Editing
Funding undisclosed
ET
Encoded Therapeutics

Gene therapy company developing precision gene therapies for debilitating neurological disorders,...

South San Francisco, United StatesBiotech, Therapeutics
Series D·$239.0M·Jul 2020
Affinia Therapeutics

An innovative gene therapy company with a proprietary platform for rationally designed adeno-asso...

Waltham, United StatesBiotech, Therapeutics
Funding undisclosed
AT
Aera Therapeutics

Biotechnology company developing next-generation genetic medicines using a proprietary protein na...

Boston, United StatesBiotech, Drug Discovery
Funding undisclosed
BH
Big Health

Digital therapeutics company providing clinically proven cognitive behavioral therapy programs fo...

San Francisco, United StatesDigital Health, Therapeutics
Funding undisclosed
OM
Ouro Medicines

Biotechnology company dedicated to developing immune reset therapeutics for people living with ch...

USABiotech, Immunology
Funding undisclosed
AT
Abata Therapeutics

Biotech company translating regulatory T cell biology into treatments for autoimmune and inflamma...

Watertown, United StatesBiotech, Immunology
Funding undisclosed
DT
Dyno Therapeutics

Biotechnology company applying artificial intelligence to design novel AAV vectors for gene thera...

Cambridge, United StatesArtificial Intelligence, Biotech
Funding undisclosed
S
Shasqi

Targeting Cancer with Click Chemistry

San Francisco, United States11–50Biotech, Healthcare
Funding undisclosed
GB
Gordian Bio
San Francisco, United StatesBiotech, Longevity
Funding undisclosed
AB
Andson Biotech

Empowering Mass Spec for Biotech and Beyond

Atlanta, United States1–10Biotech, Deep Tech
Series A·$8.3M·Oct 2025
A
Agilis
Newark, United StatesE-Commerce, Biotech
Funding undisclosed
NT
Nuntius Therapeutics

Cell-specific genetic medicines

London, United Kingdom1–10Biotech, Healthcare
Funding undisclosed
AT
Altay Therapeutics

Altay develops disease-modifying therapies targeting transcription…

San Carlos, United States1–10Biotech, Drug Discovery
Funding undisclosed
UT
Uncommon Therapeutics

A Disease Focused Biotech

San Francisco, United States1–10Biotech, Healthcare
Funding undisclosed
PB
Perception Biosystems
Closed

Democratizing gene therapy by reinventing its manufacturing and…

Palo Alto, United States1–10Biotech, Healthcare
Funding undisclosed
P
ParcelBio

Next-generation mRNA medicines

1–10Biotech, Drug Discovery
Funding undisclosed
PA
Persist AI

Developing long-lasting drug formulations 50% faster

Woodland, United States1–10Artificial Intelligence, Biotech
Funding undisclosed
OT
Origami Therapeutics, Inc.

Oral drugs to halt neurodegeneration

San Diego, United States1–10Biotech, Drug Discovery
Funding undisclosed
AP
Adventris Pharmaceuticals

Adventris makes cancer vaccines

Baltimore, United States1–10Biotech, Drug Discovery
Funding undisclosed
M
Matrubials

Developing milk-inspired therapeutics for infectious diseases

Davis, United States1–10Drug Discovery, Femtech
Funding undisclosed
IT
Intact Therapeutics

Smart gels for local drug delivery to the gut

Palo Alto, United States1–10Drug Discovery, Healthcare
Funding undisclosed
CB
Catena Biosciences

Using protein coupling to build new therapies

Berkeley, United States1–10Biotech, Healthcare
Funding undisclosed
ET
Eugit Therapeutics

Enabling Tissue Targeting of Therapies

San Carlos, United States1–10Biotech, Healthcare
Funding undisclosed